Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/17/2010 | CN101669918A Aspirin double-releasing preparation and preparation method thereof |
03/17/2010 | CN101669917A Scopolamine hydrobromide orally disintegrating microencapsule tablets based on NIMS system |
03/17/2010 | CN101669916A Method for preparing nifedipine freeze-dried powder injection |
03/17/2010 | CN101669915A Oridonin dry emulsion and preparation method thereof |
03/17/2010 | CN101669914A Pharmaceutical dosage forms for controlled release producing at least a timed pulse |
03/17/2010 | CN101669913A Levocetirizine dihydrochloride granule and preparation and detection methods thereof |
03/17/2010 | CN101669912A Slow-release composition containing tamsulosin and preparation thereof |
03/17/2010 | CN101669911A Dicazuril soluble powder and preparation method thereof |
03/17/2010 | CN101669910A Preparation of cefobutazine sodium proliposome |
03/17/2010 | CN101669909A Biological adhesive liposome preparation for eyes and preparation method thereof |
03/17/2010 | CN101669908A Preparing method of taxanes substance preparation with nanostructure |
03/17/2010 | CN101669907A Oridonin emulsion |
03/17/2010 | CN101669906A Praziquantel injection, preparation method and application thereof |
03/17/2010 | CN101669905A Thymosin alpha1 injection-type subcutaneous implant |
03/17/2010 | CN101669904A Epoprostanol lipid nanoparticle and preparation method thereof |
03/17/2010 | CN101669903A Preparation method of ibuprofen aminophenol injection |
03/17/2010 | CN101669902A Polyene phosphatidyl choline injection and preparation method thereof |
03/17/2010 | CN101669901A Liquid preparation for dosing eyes and method for making the same |
03/17/2010 | CN101669900A Polymeric delivery formulations of leuprolide with improved efficacy |
03/17/2010 | CN101669899A Sustained-release implant taking maize protein as main framework material or matrix and use thereof |
03/17/2010 | CN101669898A Medicinal preparation for injective administration and preparation method thereof |
03/17/2010 | CN101669877A Method for preparing micro medicine microspheres through spray drying |
03/17/2010 | CN100594471C Ergonomical mouse |
03/17/2010 | CN100594031C Tablet for keeping in mouth and its preparing method |
03/17/2010 | CN100594030C Externally-used Chinese traditional medicine ointment for treating paronychia |
03/17/2010 | CN100594027C Percutaneous medicine of strychnine, toxiferine, securinine and salt thereof |
03/17/2010 | CN100594025C Drop pills of hippophase rhamnoides and preparation method |
03/17/2010 | CN100594024C Permeability nose absorption type medicine for treating and preventing senile dementia, improving learning memory faculty and regulating blood brain barrier |
03/17/2010 | CN100594023C Pharmaceutical formulation |
03/16/2010 | US7678836 Method for rendering a contact lens wettable |
03/16/2010 | US7678827 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
03/16/2010 | US7678415 Method of coating fine particles with lipid film |
03/16/2010 | US7678395 stimulating the growth of hair in an area on the surface of a hair-bearing subject by administering to said area a composition that comprises isolated and purified isoginkgetin |
03/16/2010 | US7678387 Pharmaceutical, compressible, tableting and lubricating materials; caplet with a diameter and length from 1 to 7 millimeters |
03/16/2010 | US7678386 Liposomes coated with selected antibodies that bind to aminophospholipids |
03/16/2010 | US7678376 Recombinant parainfluenza virus expression systems and vaccines |
03/16/2010 | US7678367 Forming a coordination complex between bifunctional chelate compounds having a positive zeta potential and a transition metal; placing the particles on a substrate to improve deodorizing capacity; facemasks |
03/16/2010 | US7678366 for high penetration into fingernails and toenails; contains humectant for trapping water and liquid nail lacquer containing film forming agent |
03/16/2010 | US7678364 Dry powder; complex |
03/16/2010 | US7678301 Vesicles of high molecular weight silicone polyethers |
03/16/2010 | US7678146 May be used for medical indications, such as an implantable or injectable endoprostheses for mammoplastic reconstruction, implantable or injectable endoprostheses for treating (reflux) oesophagitis, and for body contouring of various body parts |
03/16/2010 | US7678103 Orifice device for delivering drugs at low fluid flow rates |
03/16/2010 | US7678071 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
03/16/2010 | CA2554169C Myocardial perfusion imaging using adenosine receptor agonists |
03/16/2010 | CA2496441C Pharmaceutical compositions of semi-ordered drugs and polymers |
03/16/2010 | CA2493277C Antipyrotic and method of manufacturing the same |
03/16/2010 | CA2492467C Injectable depot formulation comprising crystals of iloperidone |
03/16/2010 | CA2463517C Ph responsive biodegradable polylactic acid derivatives forming polymeric micelles and uses thereof for poorly water soluble drug delivery |
03/16/2010 | CA2459981C For producing biologically active products |
03/16/2010 | CA2432127C Electrostatic application of powder material to solid dosage forms in an electric field |
03/16/2010 | CA2432006C Pharmaceutical preparation with retarding active ingredient release, method for its production and its use |
03/16/2010 | CA2431521C Steroid hormone products and methods for preparing them |
03/16/2010 | CA2415378C Oral pharmaceutical composition with controlled release and prolonged absorption |
03/16/2010 | CA2395121C Composition, in particular cosmetic or dermatological composition, containing oligosaccharides and preparation method and cosmetic treatment method |
03/16/2010 | CA2390047C Valnemulin formulation |
03/16/2010 | CA2376986C Method for purification of proteins |
03/16/2010 | CA2368617C Hydrogel-forming system with hydrophobic and hydrophilic components |
03/16/2010 | CA2362772C Pharmaceutical formulation for intraveous or intramuscular octreotide administration |
03/16/2010 | CA2296334C A dispensing device and method for forming material |
03/16/2010 | CA2160693C Oral drug delivery compositions and methods |
03/12/2010 | CA2678344A1 Patch and patch preparation |
03/11/2010 | WO2010028290A1 Chewable sustained release formulations |
03/11/2010 | WO2010028211A1 Health care |
03/11/2010 | WO2010028101A1 Method for making cetirizine tablets |
03/11/2010 | WO2010028055A1 Insulin with a basal release profile |
03/11/2010 | WO2010028048A1 Brachytherapy seed with fast dissolving matrix for optimal delivery of radionuclides to cancer tissue |
03/11/2010 | WO2010028047A1 Erodible embolization material |
03/11/2010 | WO2010027921A1 Co-crystals and pharmaceutical formulations comprising the same |
03/11/2010 | WO2010027907A2 Pharmaceutical composition having relatively low ionic strength |
03/11/2010 | WO2010027851A1 Devices and systems for local delivery of inotropic agents to the epicardium |
03/11/2010 | WO2010027766A1 Lyophilized formulatons of engineered anti-il-23p19 antibodies |
03/11/2010 | WO2010027603A2 Compositions comprising solid particles encapsulated in a cross-linked silicone matrix, and methods of making the same |
03/11/2010 | WO2010027498A2 Compositions and methods for inducing satiety and treating non-insulin dependent diabetes emillitus, pre-diabetic symptoms, insulin resistance and related disease states and conditions |
03/11/2010 | WO2010027404A2 Stable solid formulation of therapeutic polypeptides suitable for oral administration |
03/11/2010 | WO2010027340A1 Pharmaceutical compositions composing entakapon, levodopa and karbidoba |
03/11/2010 | WO2010027294A1 Composition for treating dysplastic changes in the uterine cervix |
03/11/2010 | WO2010027101A1 Solid preparation for medical use |
03/11/2010 | WO2010027014A1 Method for improving absorption of s-adenosyl-l-methionine, and composition having improved s-adenosyl-l-methionine absorption |
03/11/2010 | WO2010027010A1 Pharmaceutical solid preparation having active ingredients separated by boundary therein |
03/11/2010 | WO2010026993A1 Method for improving absorbability of preparation, and preparation having improved absorbability |
03/11/2010 | WO2010026971A1 Pharmaceutical solid preparation |
03/11/2010 | WO2010026781A1 Particles, method for producing same, and gel |
03/11/2010 | WO2010026766A1 Agent for treating myelofibrosis |
03/11/2010 | WO2010026730A1 Anti-viral agent |
03/11/2010 | WO2010026701A1 Osteogenesis promoter comprising [4-(methylthio)phenylthio]methanebisphosphonic acid or pharmaceutically acceptable salt thereof as active ingredient |
03/11/2010 | WO2010026621A1 Polycationized phospholipid derivative |
03/11/2010 | WO2010026597A1 Oral dosage forms of linezolid and processes for their preparation |
03/11/2010 | WO2010026537A1 Novel multimodular assembly useful for intracellular delivery |
03/11/2010 | WO2010026470A1 Stable dosage forms of antihypertensive agents |
03/11/2010 | WO2010026300A1 Automatic gelatin capsule sorting machine |
03/11/2010 | WO2010026254A1 Prolonged release multiparticulate pharmaceutical composition comprising paliperidone |
03/11/2010 | WO2010025848A1 Particles made of ziprasidone and a pharmaceutical composition containing disintegrant |
03/11/2010 | WO2010025796A1 Tabletting of ervthritol |
03/11/2010 | WO2010025632A1 A methods for preparing the clathrate compound of steroid medicines utilizing hydrotalcite as carrier |
03/11/2010 | WO2010025631A1 A composition of extracts from plants and the use thereof in prophylaxis or treatment of metabolism disorder of blood lipid |
03/11/2010 | WO2010025589A1 Long acting curcumine derivates and preparation method thereof |
03/11/2010 | WO2010025577A2 Preparation for preventing and/or treating and/or avoiding the spreading of respiratory tract diseases |
03/11/2010 | WO2010009065A9 Organic compounds |
03/11/2010 | WO2010008719A3 Oral pharmaceutical formulations of vla-4 antagonists |
03/11/2010 | WO2010007565A3 Drug delivery garment |